CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine

被引：0
|
作者：
Heike Israel
Lars Neeb
Uwe Reuter
机构：
[1] Charité Headache Center,Charité Universitätsmedizin Berlin, Department of Neurology
来源：
Current Pain and Headache Reports | 2018年 / 22卷
关键词：
Chronic migraine; Episodic migraine; CGRP antibody; Migraine prevention; Antibody safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] CGRP plasma levels in migraine patients before and after CGRP monoclonal antibodies therapy
    Vashchenko, N.
    Uzhakhov, A.
    Bogorodskaya, M.
    Korobkova, D.
    Azimova, J.
    Skorobogatykh, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 86 - 86
  • [42] Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
    Berman, Gary
    Croop, Robert
    Kudrow, David
    Halverson, Philip
    Lovegren, Meghan
    Thiry, Alexandra C.
    Conway, Charles M.
    Coric, Vladimir
    Lipton, Richard B.
    HEADACHE, 2020, 60 (08): : 1734 - 1742
  • [43] CGRP antibodies in migraine prophylaxis The new standard in migraine treatment?
    Hamann, Till
    Rimmele, Florian
    Juergens, Tim Patrick
    SCHMERZ, 2022, 36 (01): : 59 - 72
  • [44] CGRP monoclonal antibodies early onset of efficacy following four weeks of treatment in chronic migraine
    Di Cola, Francesca Schiano
    Caratozzolo, Salvatore
    Cortinovis, Matteo
    Liberini, Paolo
    Rao, Renata
    Padovani, Alessandro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 203 - 203
  • [45] DO MULTIPLE TREATMENT CYCLES WITH ANTI-CGRP MONOCLONAL ANTIBODIES MODIFY MIGRAINE COURSE?
    Aurilia, C.
    Egeo, G.
    Proietti, S.
    Torelli, P.
    Cevoli, S.
    D'Onofrio, F.
    Bonassi, S.
    Barbanti, P.
    HEADACHE, 2023, 63 : 126 - 126
  • [46] Anti-CGRP Monoclonal Antibodies for the Treatment of Migraine with Aura: a prospective observational cohort study
    Braca, S.
    Russo, C.
    Miele, A.
    Stornaiuolo, A.
    Sansone, M.
    De Simone, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 376 - 376
  • [47] Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
    Raffaelli, Bianca
    Terhart, Maria
    Fitzek, Mira Pauline
    Lange, Kristin Sophie
    Mecklenburg, Jasper
    Overeem, Lucas Hendrik
    Siebert, Anke
    Storch, Elisabeth
    Reuter, Uwe
    PHARMACEUTICS, 2023, 15 (01)
  • [48] Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
    Giffin, Nicola J.
    PRACTICAL NEUROLOGY, 2023, 23 (03) : 200 - +
  • [49] Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
    Iannone, Luigi Francesco
    De Cesaris, Francesco
    Ferrari, Anita
    Benemei, Silvia
    Fattori, Davide
    Chiarugi, Alberto
    CEPHALALGIA, 2022, 42 (13) : 1323 - 1330
  • [50] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Amy R. Tso
    Peter J. Goadsby
    Current Treatment Options in Neurology, 2017, 19
12345